Leung M, Swanton C, McGranahan N
Nat Rev Genet. 2025; .
PMID: 40065153
DOI: 10.1038/s41576-025-00825-2.
Wang F, Wang C, Chen S, Wei C, Ji J, Liu Y
Mol Cancer. 2025; 24(1):60.
PMID: 40025576
PMC: 11871737.
DOI: 10.1186/s12943-025-02271-4.
Tagore S, Caprio L, Amin A, Bestak K, Luthria K, DSouza E
Nat Med. 2025; .
PMID: 40016452
DOI: 10.1038/s41591-025-03530-z.
Park Y, Hwang Y, Jeong J, Lee C, Kim M, Jo S
Cell Death Discov. 2025; 11(1):60.
PMID: 39952933
PMC: 11829039.
DOI: 10.1038/s41420-025-02332-z.
Zhang P, Wang L, Liu H, Lin S, Guo D
BMC Cancer. 2025; 25(1):249.
PMID: 39948531
PMC: 11823056.
DOI: 10.1186/s12885-025-13650-x.
GATA3-Driven ceRNA Network in Lung Adenocarcinoma Bone Metastasis Progression and Therapeutic Implications.
Liu Y, Shen S, Wang X, Chen H, Ren W, Wei H
Cancers (Basel). 2025; 17(3).
PMID: 39941924
PMC: 11816722.
DOI: 10.3390/cancers17030559.
Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer.
Mzoughi S, Schwarz M, Wang X, Demircioglu D, Ulukaya G, Mohammed K
Nat Genet. 2025; 57(2):402-412.
PMID: 39930084
PMC: 11821538.
DOI: 10.1038/s41588-024-02058-1.
Rab21-Targeted Nano Drug Delivery System-Based FFPG for Efficient Paclitaxel Delivery to Inhibit Lung Cancer Progression.
Wang J, Yan X, Wang W, Wang S, Jiang H, Zhu X
Pharmaceutics. 2025; 17(1).
PMID: 39861741
PMC: 11768108.
DOI: 10.3390/pharmaceutics17010094.
Promoting epithelial regeneration in chemically induced acute lung injury through Sox9-positive alveolar type 2 epithelial cells.
Cao C, Memete O, Dun Y, Zhang L, Liu F, He D
Stem Cell Res Ther. 2025; 16(1):13.
PMID: 39849583
PMC: 11756119.
DOI: 10.1186/s13287-024-04124-1.
Utilizing sc-linker to integrate single-cell RNA sequencing and human genetics to identify cell types and driver genes associated with non-small cell lung cancer.
Zhou Y, Zhao L, Cai M, Luo D, Pang Y, Chen J
BMC Cancer. 2025; 25(1):130.
PMID: 39849454
PMC: 11755902.
DOI: 10.1186/s12885-025-13525-1.
inDrops-2: a flexible, versatile and cost-efficient droplet microfluidic approach for high-throughput scRNA-seq of fresh and preserved clinical samples.
Juzenas S, Goda K, Kiseliovas V, Zvirblyte J, Quintinal-Villalonga A, Siurkus J
Nucleic Acids Res. 2025; 53(2).
PMID: 39797728
PMC: 11724362.
DOI: 10.1093/nar/gkae1312.
Mutation-Driven Immune Microenvironments in Non-Small Cell Lung Cancer: Unrevealing Patterns through Cluster Analysis.
Kim Y, Hwang J, Na K, Kim D, Lee S, Kang S
Yonsei Med J. 2024; 65(12):683-694.
PMID: 39609084
PMC: 11605048.
DOI: 10.3349/ymj.2024.0062.
Vaping and tumor metastasis: current insights and progress.
Xi Y, Yang L, Burtness B, Wang H
Cancer Metastasis Rev. 2024; 44(1):4.
PMID: 39581913
PMC: 11792352.
DOI: 10.1007/s10555-024-10221-7.
Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer.
Patel R, Parappilly M, Farley H, Latour E, Wang L, Nair A
Cancers (Basel). 2024; 16(21).
PMID: 39518088
PMC: 11545756.
DOI: 10.3390/cancers16213650.
Integrated analysis of single-cell and bulk RNA-sequencing identifies a metastasis-related gene signature for predicting prognosis in lung adenocarcinoma.
Cao X, Xi J, Wang C, Yu W, Wang Y, Zhu J
Clin Transl Oncol. 2024; .
PMID: 39516442
DOI: 10.1007/s12094-024-03752-6.
Progressive plasticity during colorectal cancer metastasis.
Moorman A, Moorman A, Benitez E, Benitez E, Cambuli F, Cambulli F
Nature. 2024; 637(8047):947-954.
PMID: 39478232
PMC: 11754107.
DOI: 10.1038/s41586-024-08150-0.
Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers.
Luo Y, Liang H
Genome Med. 2024; 16(1):124.
PMID: 39468667
PMC: 11514945.
DOI: 10.1186/s13073-024-01393-6.
TGF-β induces an atypical EMT to evade immune mechanosurveillance in lung adenocarcinoma dormant metastasis.
Wang Z, Elbanna Y, Godet I, Peters L, Lampe G, Chen Y
bioRxiv. 2024; .
PMID: 39463937
PMC: 11507679.
DOI: 10.1101/2024.10.15.618357.
Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer.
Tokhanbigli S, Haghi M, Dua K, Oliver B
Cancer Drug Resist. 2024; 7:32.
PMID: 39403603
PMC: 11472577.
DOI: 10.20517/cdr.2024.55.
Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance.
Jamroze A, Liu X, Tang D
Cancer Heterog Plast. 2024; 1(1).
PMID: 39363904
PMC: 11449474.
DOI: 10.47248/chp2401010005.